AMAG Pharmaceuticals, Inc.
(NASDAQ : AMAG)

( )
AMAG After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 0.65%40.350.9%$2406.88m
JNJJohnson & Johnson 0.83%150.240.7%$1152.56m
ABBVAbbVie, Inc. 2.42%107.271.9%$937.70m
MRKMerck & Co., Inc. 0.57%81.910.7%$681.87m
BMYBristol-Myers Squibb Co. 0.85%62.311.0%$627.96m
LLYEli Lilly & Co. 3.05%148.501.1%$611.14m
AZNAstraZeneca Plc 1.82%53.741.2%$375.21m
TTNPTitan Pharmaceuticals, Inc. -3.85%3.5017.1%$266.44m
GSKGlaxoSmithKline Plc 0.62%37.500.2%$214.98m
NVSNovartis AG 1.52%91.610.2%$191.99m
ARCTArcturus Therapeutics Holdings, Inc. 12.79%112.010.0%$146.59m
RGENRepligen Corp. 0.60%188.337.1%$92.93m
SBTXSilverback Therapeutics, Inc. 19.05%25.000.0%$88.29m
KNTEKinnate Biopharma, Inc. 11.35%43.460.0%$86.26m
NVONovo Nordisk A/S 0.89%67.810.1%$83.43m

Company Profile

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.